| Literature DB >> 27355472 |
Athmanya K Eshwar1, Ben D Tall2, Jayanthi Gangiredla2, Gopal R Gopinath2, Isha R Patel2, Stephan C F Neuhauss3, Roger Stephan1, Angelika Lehner1.
Abstract
Bacteria belonging to the genus Cronobacter have been recognized as causative agents of life-threatening systemic infections primarily in premature, low-birth weight and immune-compromised neonates. Apparently not all Cronobacter species are linked to infantile infections and it has been proposed that virulence varies among strains. Whole genome comparisons and in silico analysis have proven to be powerful tools in elucidating potential virulence determinants, the presence/absence of which may explain the differential virulence behaviour of strains. However, validation of these factors has in the past been hampered by the availability of a suitable neonatal animal model. In the present study we have used zebrafish embryos to model Cronobacter infections in vivo using wild type and genetically engineered strains. Our experiments confirmed the role of the RepF1B-like plasmids as "virulence plasmids" in Cronobacter and underpinned the importantce of two putative virulence factors-cpa and zpx-in in vivo pathogenesis. We propose that by using this model in vivo infection studies are now possible on a large scale level which will boost the understanding on the virulence strategies employed by these pathogens.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27355472 PMCID: PMC4927158 DOI: 10.1371/journal.pone.0158428
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Wild type strains used in the zebrafish embryo infection experiments.
| Species | Strain ID ATCC | O type | Sequence type | Source and/or reference |
|---|---|---|---|---|
| LMG 26250T | O1 | 98 | Spiced meat [ | |
| LMG 23823T | O1b | 106 | Milk powder processing environment [ | |
| LMG 23815 | O1a | 79 | Milk powder processing environment [ | |
| LMG 23824 | O2 | 80 | Basin of a water fountain [ | |
| LMG 23826T | O2 | 7 | Human breast abscess [ | |
| ATCC 51329T | O2 | 81 | Unknown [ | |
| ATCC 29544T | O1 | 8 | Child throat [ | |
| ATCC BAA-894 | O1 | 1 | Milk powder [ | |
| E899 | O2 | 4 | Clinical | |
| LMG 23827T | O1 | 19 | Neonate [ | |
| LMG 26249T | O1 | 54 | Water [ | |
| Xl1 blue | n. a. | n.a. | Agilent |
a: ATCC = American Type Culture Collection, Manassas, USA
b: LMG = BCCM/LMG Laboratorium voor Microbiologie, Universiteit Gent, Gent, Belgium
*: Type culture collection Institute for Food Safety and Hygiene, University Zurich, Zurich, Switzerland, O serotyped and MLST typed by Center for Food Safety and Applied Nutrition FDA, Laurel, Maryland, USA
c, d: O (Sero)type and MLST Sequence type designations retrieved from Ogrodzki and Forsythe [27].
n. a.: not applicable
Material used for zpx mutant construction and complementation.
| Strains/plasmids/primers | Genotype/characteristic(s)/sequences | Source or reference |
|---|---|---|
| Mutant construction strains | ||
| Acceptor for transconjugation, NalR | [ | |
| Host for pDS132::Δ | [ | |
| Host for cloning vector pDS132; | [ | |
| Donor for transconjugation, harbouring construct pDS132::Δ | This study | |
| Plasmids | ||
| pDS132 | Low copy cloning vector R6K | [ |
| pDS132::Δ | Δ | This study |
| Primers | ||
| zpxF1f | This study | |
| zpxF1r | This study | |
| zpxF2fmod | This study | |
| zpxF2r | This study | |
| zpxConf | This study | |
| zpxConr | This study | |
| Complementation | ||
| Template for amplification of | [ | |
| Zpx CDS mutant, cloning host for pQE-30, pQE-30:: | This study | |
| Mutant transformant harbouring expression cloning vector pQE-30, AmpR | This study | |
| Mutant transformant harbouring construct pQE-30:: | This study | |
| Plasmid | ||
| pQE-30 | Cloning/expression vector, AmpR | Qiagen |
| Primers | ||
| rpfFComplf | This study | |
| rpfFComplr | This study | |
| Insert control | ||
| pQE-30mcsf | Qiagen | |
| pQE-30r | Qiagen |
Fig 1A, B. Zebrafish embryo infection experiments performed with Cronobacter wt strains.
n = 30 embryos per strain, p = < 0.0001.
Fig 2Infection experiments using C. turicensis LMG 23827T, C. sakazakii ATCC BAA-894 wt, the (pESA3, pCTU1) plasmid-cured strains, and C. sakazakii E899 strain naturally devoid of the pESA3 plasmid.
n = 30 per strain, p = 0.0007.
Fig 3Infection experiments using the C. sakazakii ATCC BAA-894 wt, the cpa mutant and control strains.
n = 30 embryos per strain, p < 0.0001.
Fig 4Quantitative infection experiments using C. sakazakii ATCC BAA-894 wt and the cpa mutant.
Fig 5Infection experiments using the C. sakazakii ATCC BAA-894 wt, the zpx mutant and control strains.
n = 30 embryos per strain, p < 0.0001.